United Kingdom
www.gsk.com
Sales: $2.1 billion

Sales: 

$2.1 billion for oral care. Corporate sales: $45.4 billion.  

Key Personnel:

Andrew Witty, chief executive officer; John Clarke, president, consumer healthcare.

Major Products:

Toothpaste and mouthwash—Aquafresh, Dr. Best, Macleans, Odol, Odol Med 2, Polident, Polygrip, Sensodyne; Denture care—Polident, Polygrip, Corega.

New Products:

Aquafresh iso-active foaming gel

Comments:

GSK’s oral care sales rose 8% to nearly $2.1 billion. Sales of Aquafresh rose 12%, spurred by the success of new Aquafresh White Trays. Sensodyne’s sales jumped 16%, driven by Senosdyne ProNamel.
   
GSK is touting Aquafresh iso-active foaming gel, a new foaming gel proven to remove significantly more anaerobic bacteria and volatile sulphur compound (VSC)-producing organisms than ordinary toothpaste. According to the company, the gel-to-foam action generates twice the volume of ordinary toothpaste, spreads ingredients and penetrates hard-to-reach places to help remove debris and bacteria and fight odor.
     
GSK is squarely committed to promoting oral care health from both a professional and consumer standpoint. Along those lines, in November GSK inaugurated the Aquafresh Science Academy in Weybridge, UK. Supported by a global website, GSK aims to provide a valuable information resource for dental professionals across the world. More recently, GSK unveiled a $7 million campaign in the UK featuring its five main oral care brands—Aquafresh, Corsodyl, Macleans, Poligrip and Sensodyne. The campaign’s website, www.loveyourmouth.co.uk, features a “mouth match” test that helps consumers find products that will deliver the oral health benefits they need.